NCT03057483View on ClinicalTrials.gov

Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute

CompletedOBSERVATIONAL

Enrollment

533

Participants

Timeline

Start Date

April 6, 2017

Primary Completion Date

September 6, 2017

Study Completion Date

December 6, 2017

Conditions

Influenza Vaccines

Interventions

BIOLOGICAL

Seasonal Influenza vaccine

Seasonal Influenza vaccine

Trial Locations (2)

69304000

UBS Buritis, Boa Vista

Unknown

Crie - Unifesp, São Paulo

Sponsors

Lead Sponsor

Butantan Institute

All Listed Sponsors

lead

Butantan Institute

OTHER_GOV